Abstract
Stereotactic radiosurgery (SRS) can be an effective primary or adjuvant treatment option for intracranial tumors. However, it carries risks of various radiation toxicities, including radionecrosis and functional deficits. Current SRS inverse planning algorithms allow efficient inclusion of organs at risk (OARs) in the treatment planning process, which will be spared by setting a maximum radiation dose. In this work we propose using activation maps from functional MRI to map the eloquent regions of the brain and define functional OARs. We evaluate the effects of these functional OARs for Elekta Leksell Gamma Knife SRS inverse treatment planning on open data MRI from 5 subjects. Our results show that fMRI-derived functional OARs can effectively be used to reduce the radiation dose incident on the eloquent brain regions, while maintaining acceptable treatment planning metrics on the tumor targets.
Competing Interest Statement
The authors declare: no financial relationships with, or funding from, any organizations that might have an interest in the submitted work; Elekta Instruments AB provided a preclinical version of the GammaPlan software to the authors, as well as assistance in its usage; no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This study was supported by CENIIT at Linköping University, by the ITEA3 / VINNOVA funded project "Intelligence based iMprovement of Personalized treatment And Clinical workflow supporT" (IMPACT), by LiU cancer at Linköping University, and by the ITEA3 / VINNOVA funded project "Automation, Surgery Support and Intuitive 3D visualization to optimize workflow in IGT SysTems" (ASSIST). The authors did not receive any funding from Elekta Instrument AB.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Linköping waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This work used open data published in Pernet et al., 2016, "A structural and functional magnetic resonance imaging dataset of brain tumour patients".
